What are the major opportunities in the Malignant Pleural Effusion market? What are the strategies for the Malignant Pleural Effusion market?

For detailed insights on the major opportunities and strategies in the Malignant Pleural Effusion market, Read More

How does the Malignant Pleural Effusion market relate to the overall economy and other similar markets?

For detailed insights on Malignant Pleural Effusion's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Malignant Pleural Effusion market growth? SWOT analysis of the Malignant Pleural Effusion market.

For detailed insights on the key dynamics influencing the Malignant Pleural Effusion market growth and SWOT analysis of the Malignant Pleural Effusion industry, Read More

Malignant Pleural Effusion Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Malignant Pleural Effusion Market Report 2026

Name: Malignant Pleural Effusion Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter), By Diagnosis (Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy), By End Users (Hospitals, Ambulatory Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Malignant Pleural Effusion Market Overview

• Malignant Pleural Effusion market size has reached to $4.73 billion in 2025

• Expected to grow to $6.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Rising Cases Of Lung Cancer Driving The Growth Of The Market Due To Increasing Treatment Demand

• Market Trend: Advanced, Minimally Invasive Solutions To Improve Outcomes In Malignant Pleural Effusion Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Malignant Pleural Effusion Market?

Malignant pleural effusion (MPE) refers to the accumulation of fluid in the pleural space due to the presence of cancer cells, typically resulting from metastatic disease. This condition occurs when cancer spreads to the pleura, the thin membrane surrounding the lungs, leading to increased vascular permeability and impaired lymphatic drainage.

The main treatment types for malignant pleural effusion include systemic therapy, therapeutic thoracentesis, thoracic drainage and pleurodesis, and indwelling pleural catheter placement. Systemic therapy is a cancer treatment that circulates through the bloodstream to target and eliminate cancer cells throughout the body. This is diagnosed using various methods, such as pleural fluid cytology, immunohistochemical tests, imaging tests, pleural thoracentesis, pleuroscopy, and pleural biopsy. These treatments and diagnostic methods are utilized by various end users, including hospitals, ambulatory clinics, and other healthcare facilities.

Malignant Pleural Effusion Market Global Report 2026 Market Report bar graph

What Is The Malignant Pleural Effusion Market Size and Share 2026?

The malignant pleural effusion market size has grown strongly in recent years. It will grow from $4.73 billion in 2025 to $5.05 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing incidence of metastatic cancers, limited curative treatment options, reliance on repeated thoracentesis for symptom control, growing hospital-based cancer care, gradual adoption of pleurodesis techniques.

What Is The Malignant Pleural Effusion Market Growth Forecast?

The malignant pleural effusion market size is expected to see strong growth in the next few years. It will grow to $6.52 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising cancer prevalence worldwide, advancements in pleural catheter technologies, increasing emphasis on outpatient and home-based care, improved diagnostic imaging accuracy, growing demand for quality-of-life–focused treatments. Major trends in the forecast period include increasing use of indwelling pleural catheters for long-term management, rising preference for minimally invasive pleural interventions, growing integration of systemic cancer therapies in mpe management, higher focus on symptom relief and palliative care approaches, expansion of imaging-guided diagnostic and therapeutic procedures.

Book your 30 minutes free consultation with our research experts

Global Malignant Pleural Effusion Market Segmentation

1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter

2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy

3) By End Users: Hospitals, Ambulatory Clinics, Other End Users

Subsegments:

1) By Systemic Therapy: Chemotherapy, Targeted Therapy, Immunotherapy

2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis

3) By Thoracic Drainage And Pleurodesis: Chemical Pleurodesis, Mechanical Pleurodesis

4) By Indwelling Pleural Catheter: Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter

What Are The Drivers Of The Malignant Pleural Effusion Market?

The rising cases of lung cancer is expected to propel the growth of the malignant pleural effusion market going forward. Lung cancer is a disease characterized by the uncontrolled growth of abnormal cells in the lungs, which can form tumors and interfere with normal lung function. The rising cases of lung cancer are due to smoking and tobacco use, as prolonged exposure to harmful chemicals in cigarettes damages lung tissues, triggers genetic mutations, and promotes the uncontrolled growth of cancerous cells, significantly increasing the likelihood of developing the disease. Malignant pleural effusion indicates advanced lung cancer progression by facilitating tumor spread within the pleural cavity, leading to worsened respiratory function and a poorer prognosis. For instance, in January 2023, according to the American Cancer Society Facts and Figures, a US-based professional organizations company, the estimated number of new lung and bronchus cancer cases was 236,740 in 2022 and 238,340 in 2023, while the estimated deaths were 130,180 in 2022 and 127,070 in 2023. Therefore, the rising cases of lung cancer is driving the growth of the malignant pleural effusion industry.

The improving healthcare infrastructure is expected to propel the growth of the malignant pleural effusion market going forward. Healthcare infrastructure refers to the physical, technological, and organizational structures required for delivering healthcare services, including hospitals, clinics, medical equipment, IT systems, and workforce. Improving healthcare infrastructure is attributed to need for better disease management, all of which contribute to enhanced healthcare accessibility, efficiency, and quality of care. Improving healthcare infrastructure enhances the diagnosis, treatment, and management of malignant pleural effusion by enabling access to advanced medical technologies, better-equipped healthcare facilities, and specialized care, ultimately improving patient outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the United States increased by 0.591% from the previous year, rising from 6,093 to 6,129. Therefore, the improving healthcare infrastructure is driving the growth of the malignant pleural effusion industry.

Key Players In The Global Malignant Pleural Effusion Market

Major companies operating in the malignant pleural effusion market are Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc, Argon Medical Devices Inc, B Braun SE, Medtronic plc, Smiths Medical, Teleflex Incorporated, Cardinal Health Inc, Getinge AB, AngioDynamics Inc, Rocket Medical plc, Redax SpA, Atrium Medical Corporation, PolyMedicure Ltd, Troge Medical GmbH, Vygon SA, ICU Medical Inc, ConvaTec Group plc, Baxter International Inc

Global Malignant Pleural Effusion Market Trends and Insights

Major companies operating in the malignant pleural effusion market are focusing on developing innovative products such as fully-implantable automatic fluid-shunt devices to improve patient comfort and reduce hospital visits. A fully-implantable automatic fluid-shunt device is a medical device implanted in the body that automatically drains excess pleural fluid from the lungs into the abdomen or another area, helping to relieve symptoms of breathlessness, reduce the need for repeated hospital procedures, and improve patient quality of life. For instance, in October 2023, Pleural Dynamics, a US-based medical device company, launched the ACES Automatic Continuous Effusion Shunt System. This device comprises a resilient flexible pump chamber implanted under the skin between the ribs, with one catheter in the pleural space and another in the peritoneal space. As the patient breathes, the internal pump extension is compressed and decompressed between adjacent ribs, driving fluid from the pleural cavity to the abdomen where it is reabsorbed; the system also allows manual activation via an external compression extension. Key features include: fully implantable design, no external drainage tubing or suction bottles, breathing-powered automatic pumping function, minimal hospital stay for implantation, and continuous symptom relief from recurrent effusions.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

North America was the largest region in the malignant pleural effusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Malignant Pleural Effusion Market?

The malignant pleural effusion market consists of revenues earned by entities by providing services such as biopsy and cytology testing, chemotherapy and targeted therapy, and pleurodesis. The market value includes the value of related goods sold by the service provider or included within the service offering. The malignant pleural effusion market also includes sales of chest drainage systems, pleural access kits, and imaging-guided drainage equipment, and thoracentesis devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Malignant Pleural Effusion Market Report 2026?

The malignant pleural effusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the malignant pleural effusion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Malignant Pleural Effusion Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.05 billion
Revenue Forecast In 2035	$6.52 billion
Growth Rate	CAGR of 6.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Diagnosis, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc, Argon Medical Devices Inc, B Braun SE, Medtronic plc, Smiths Medical, Teleflex Incorporated, Cardinal Health Inc, Getinge AB, AngioDynamics Inc, Rocket Medical plc, Redax SpA, Atrium Medical Corporation, PolyMedicure Ltd, Troge Medical GmbH, Vygon SA, ICU Medical Inc, ConvaTec Group plc, Baxter International Inc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Malignant Pleural Effusion Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Malignant Pleural Effusion Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Malignant Pleural Effusion Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Malignant Pleural Effusion Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Indwelling Pleural Catheters For Long-Term Management

4.2.2 Rising Preference For Minimally Invasive Pleural Interventions

4.2.3 Growing Integration Of Systemic Cancer Therapies In Mpe Management

4.2.4 Higher Focus On Symptom Relief And Palliative Care Approaches

4.2.5 Expansion Of Imaging-Guided Diagnostic And Therapeutic Procedures

5. Malignant Pleural Effusion Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ambulatory Clinics

5.3 Oncology Centers

5.4 Pulmonology Clinics

5.5 Palliative Care Centers

6. Malignant Pleural Effusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Malignant Pleural Effusion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Malignant Pleural Effusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Malignant Pleural Effusion Market Size, Comparisons And Growth Rate Analysis

7.3. Global Malignant Pleural Effusion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Malignant Pleural Effusion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Malignant Pleural Effusion Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Malignant Pleural Effusion Market Segmentation

9.1. Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter

9.2. Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy

9.3. Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Clinics, Other End Users

9.4. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Targeted Therapy, Immunotherapy

9.5. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Time Thoracentesis, Repeated Thoracentesis

9.6. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemical Pleurodesis, Mechanical Pleurodesis

9.7. Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter

10. Malignant Pleural Effusion Market Regional And Country Analysis

10.1. Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Malignant Pleural Effusion Market

11.1. Asia-Pacific Malignant Pleural Effusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Malignant Pleural Effusion Market

12.1. China Malignant Pleural Effusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Malignant Pleural Effusion Market

13.1. India Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Malignant Pleural Effusion Market

14.1. Japan Malignant Pleural Effusion Market Overview

14.2. Japan Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Malignant Pleural Effusion Market

15.1. Australia Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Malignant Pleural Effusion Market

16.1. Indonesia Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Malignant Pleural Effusion Market

17.1. South Korea Malignant Pleural Effusion Market Overview

17.2. South Korea Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Malignant Pleural Effusion Market

18.1. Taiwan Malignant Pleural Effusion Market Overview

18.2. Taiwan Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Malignant Pleural Effusion Market

19.1. South East Asia Malignant Pleural Effusion Market Overview

19.2. South East Asia Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Malignant Pleural Effusion Market

20.1. Western Europe Malignant Pleural Effusion Market Overview

20.2. Western Europe Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Malignant Pleural Effusion Market

21.1. UK Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Malignant Pleural Effusion Market

22.1. Germany Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Malignant Pleural Effusion Market

23.1. France Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Malignant Pleural Effusion Market

24.1. Italy Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Malignant Pleural Effusion Market

25.1. Spain Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Malignant Pleural Effusion Market

26.1. Eastern Europe Malignant Pleural Effusion Market Overview

26.2. Eastern Europe Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Malignant Pleural Effusion Market

27.1. Russia Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Malignant Pleural Effusion Market

28.1. North America Malignant Pleural Effusion Market Overview

28.2. North America Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Malignant Pleural Effusion Market

29.1. USA Malignant Pleural Effusion Market Overview

29.2. USA Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Malignant Pleural Effusion Market

30.1. Canada Malignant Pleural Effusion Market Overview

30.2. Canada Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Malignant Pleural Effusion Market

31.1. South America Malignant Pleural Effusion Market Overview

31.2. South America Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Malignant Pleural Effusion Market

32.1. Brazil Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Malignant Pleural Effusion Market

33.1. Middle East Malignant Pleural Effusion Market Overview

33.2. Middle East Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Malignant Pleural Effusion Market

34.1. Africa Malignant Pleural Effusion Market Overview

34.2. Africa Malignant Pleural Effusion Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Malignant Pleural Effusion Market Regulatory and Investment Landscape

36. Malignant Pleural Effusion Market Competitive Landscape And Company Profiles

36.1. Malignant Pleural Effusion Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Malignant Pleural Effusion Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Malignant Pleural Effusion Market Company Profiles

36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Cook Medical LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merit Medical Systems Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Argon Medical Devices Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. B Braun SE Overview, Products and Services, Strategy and Financial Analysis

37. Malignant Pleural Effusion Market Other Major And Innovative Companies

Medtronic plc, Smiths Medical, Teleflex Incorporated, Cardinal Health Inc, Getinge AB, AngioDynamics Inc, Rocket Medical plc, Redax SpA, Atrium Medical Corporation, PolyMedicure Ltd, Troge Medical GmbH, Vygon SA, ICU Medical Inc, ConvaTec Group plc, Baxter International Inc

38. Global Malignant Pleural Effusion Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Malignant Pleural Effusion Market

40. Malignant Pleural Effusion Market High Potential Countries, Segments and Strategies

40.1 Malignant Pleural Effusion Market In 2030 - Countries Offering Most New Opportunities

40.2 Malignant Pleural Effusion Market In 2030 - Segments Offering Most New Opportunities

40.3 Malignant Pleural Effusion Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Malignant Pleural Effusion Market, Overview Of Key Products - Product Examples

Table 2: Global Malignant Pleural Effusion Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Malignant Pleural Effusion Market, Supply Chain Analysis

Table 4: Global Malignant Pleural Effusion Market, Major Raw Material Providers

Table 5: Global Malignant Pleural Effusion Market, Major Resource Providers

Table 6: Global Malignant Pleural Effusion Market, Major Manufacturers (Suppliers)

Table 7: Global Malignant Pleural Effusion Market, Major Distributors And Channel Partners

Table 8: Global Malignant Pleural Effusion Market, Key Technologies & Future Trends

Table 9: Global Malignant Pleural Effusion Market, Major Trends

Table 10: Global Malignant Pleural Effusion Market, Major End Users

Table 11: Global Malignant Pleural Effusion Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Malignant Pleural Effusion Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Malignant Pleural Effusion Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Malignant Pleural Effusion Market - TAM, US$ Billion, 2025

Table 15: Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Malignant Pleural Effusion Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Malignant Pleural Effusion Market - Company Scoring Matrix

Table 98: Becton Dickinson and Company Financial Performance

Table 99: Cook Medical LLC Financial Performance

Table 100: Merit Medical Systems Inc Financial Performance

Table 101: Argon Medical Devices Inc Financial Performance

Table 102: B Braun SE Financial Performance

Table 103: Global Malignant Pleural Effusion Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Malignant Pleural Effusion Market, Competitive Dashboard

Table 105: Global Malignant Pleural Effusion Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 107: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 108: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

Figure 1: Global Malignant Pleural Effusion Market, Overview Of Key Products - Product Examples

Figure 2: Global Malignant Pleural Effusion Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Malignant Pleural Effusion Market, Supply Chain Analysis

Figure 4: Global Malignant Pleural Effusion Market, Major Raw Material Providers

Figure 5: Global Malignant Pleural Effusion Market, Major Resource Providers

Figure 6: Global Malignant Pleural Effusion Market, Major Manufacturers (Suppliers)

Figure 7: Global Malignant Pleural Effusion Market, Major Distributors And Channel Partners

Figure 8: Global Malignant Pleural Effusion Market, Key Technologies & Future Trends

Figure 9: Global Malignant Pleural Effusion Market, Major Trends

Figure 10: Global Malignant Pleural Effusion Market, Major End Users

Figure 11: Global Malignant Pleural Effusion Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Malignant Pleural Effusion Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Malignant Pleural Effusion Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Malignant Pleural Effusion Market - TAM, US$ Billion, 2025

Figure 15: Global Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Systemic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Therapeutic Thoracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Thoracic Drainage And Pleurodesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Malignant Pleural Effusion Market, Sub-Segmentation Of Indwelling Pleural Catheter, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Malignant Pleural Effusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Malignant Pleural Effusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Malignant Pleural Effusion Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Malignant Pleural Effusion Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Malignant Pleural Effusion Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Malignant Pleural Effusion Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Malignant Pleural Effusion Market - Company Scoring Matrix

Figure 98: Becton Dickinson and Company Financial Performance

Figure 99: Cook Medical LLC Financial Performance

Figure 100: Merit Medical Systems Inc Financial Performance

Figure 101: Argon Medical Devices Inc Financial Performance

Figure 102: B Braun SE Financial Performance

Figure 103: Global Malignant Pleural Effusion Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Malignant Pleural Effusion Market, Competitive Dashboard

Figure 105: Global Malignant Pleural Effusion Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 107: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 108: Global, Malignant Pleural Effusion Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Pulmonary Embolism Market Report 2026 - Global Outlook – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed To...

Esophageal Cancer Market Report 2026 - Global Outlook – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By ...

Aortic Aneurysm Market Report 2026 - Global Outlook – By Type (Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA)), By Treatment (Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR)), By End User...

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Global Outlook – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laser Therapy, Photodynamic Therapy...

Embolization Coils Market Report 2026 - Global Outlook – By Type (Detachable Coil, Pushable Coil), By Material (Platinum, Platinum And Hydrogel, Platinum Tungsten Alloy), By Application (Neurology, Urology, Peripheral Va...

Tumor Ablation Market Report 2026 - Global Outlook – By Type (Thermal Ablation, Chemical Ablation), By Types Of Treatment (Percutaneous, Laparoscopic, Surgical), By Application (Kidney Cancer, Liver Cancer, Breast Cancer...

Interstitial Lung Disease Market Report 2026 - Global Outlook – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonar...

Frequently Asked Questions

How big is the Malignant Pleural Effusion Market?

The Malignant Pleural Effusion market was valued at $4.73 billion in 2025, increased to $5.05 billion in 2026, and is projected to reach $6.52 billion by 2030.

What is the Malignant Pleural Effusion market growth?

The global Malignant Pleural Effusion market is expected to grow at a CAGR of 6.6% from 2026 to 2035 to reach $6.52 billion by 2035.

Who are the key players in Malignant Pleural Effusion market?

Some Key Players in the Malignant Pleural Effusion market Include, Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc, Argon Medical Devices Inc, B Braun SE, Medtronic plc, Smiths Medical, Teleflex Incorporated, Cardinal Health Inc, Getinge AB, AngioDynamics Inc, Rocket Medical plc, Redax SpA, Atrium Medical Corporation, PolyMedicure Ltd, Troge Medical GmbH, Vygon SA, ICU Medical Inc, ConvaTec Group plc, Baxter International Inc .

What is the anticipated growth trend for the Malignant Pleural Effusion market?

Major trend in this market includes: Advanced, Minimally Invasive Solutions To Improve Outcomes In Malignant Pleural Effusion Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Malignant Pleural Effusion market?

North America was the largest region in the malignant pleural effusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant pleural effusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.